Valeo Pharma Inc. (VPHIF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.69 Million | -28.5 Million | -12.31 Million | -5.29 Million | -2.3 Million | -1.33 Million |
| Net Income | -27.8 Million | -25.74 Million | -14.23 Million | -4.76 Million | -3.61 Million | -2.43 Million |
| Depreciation & Amortization | 2.62 Million | 1.41 Million | 743 Thousand | 424 Thousand | 135 Thousand | 44.47 Thousand |
| Deferred income taxes | 1.85 Million | -1.17 Million | 530 Thousand | 312 Thousand | 113 Thousand | 15.04 Thousand |
| Stock-based compensation | 870 Thousand | 941 Thousand | 996 Thousand | 469 Thousand | 325 Thousand | 78 Thousand |
| Change in working capital | 4.21 Million | -11.48 Million | -1.41 Million | -2.23 Million | 645 Thousand | 791.96 Thousand |
| Other non-cash items | 2.54 Million | 7.54 Million | 1.06 Million | 497 Thousand | 90 Thousand | 174.38 Thousand |
| Investing Cash Flow | -5.55 Million | -6.89 Million | -3.46 Million | -1.4 Million | -923 Thousand | 62.89 Thousand |
| Investments in PPE | -5.55 Million | -6.89 Million | -3.46 Million | -1.4 Million | -945 Thousand | -323.21 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5.07 Million | -6.53 Million | -2.56 Million | -1.34 Million | 22 Thousand | 386.1 Thousand |
| Financing Cash Flow | 6.18 Million | 54.99 Million | 15.1 Million | 9.2 Million | 3.55 Million | 1.28 Million |
| Debt repayment | -224 Thousand | -1.66 Million | -4.94 Million | -875 Thousand | -947 Thousand | -130 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.92 Million | 394 Thousand | 11.5 Million | 7.24 Million | 3.11 Million | - |
| Other Financing Activities | 2.49 Million | 56.26 Million | 8.54 Million | 2.83 Million | 1.38 Million | 1.41 Million |
| Accounts receivables | -1.13 Million | -5.21 Million | -384 Thousand | -710 Thousand | 350 Thousand | -603.85 Thousand |
| Accounts payables | 3.02 Million | -4.01 Million | 6.41 Million | -775 Thousand | 958 Thousand | 722.76 Thousand |
| Inventory | -1.77 Million | -3.81 Million | -6.98 Million | -525 Thousand | -468 Thousand | -179.74 Thousand |
| Other working capital | 4.09 Million | 1.56 Million | -464 Thousand | -229 Thousand | -195 Thousand | 852.8 Thousand |
| Cash at beginning of period | 22.5 Million | 2.04 Million | 2.83 Million | 335 Thousand | 11 Thousand | 3277.00 |
| Cash at end of period | 7.5 Million | 22.5 Million | 2.04 Million | 2.83 Million | 335 Thousand | 11.46 Thousand |
| Capital Expenditure | -5.55 Million | -6.89 Million | -3.46 Million | -1.4 Million | -945 Thousand | -323.21 Thousand |
| Effect of forex changes on cash | 60 Thousand | 861 Thousand | -117 Thousand | -3000.00 | 1000.00 | -4381.00 |
| Net cash flow / Change in cash | -14.99 Million | 20.45 Million | -793 Thousand | 2.5 Million | 324 Thousand | 8192.00 |
| Free Cash Flow | -21.24 Million | -35.39 Million | -15.78 Million | -6.7 Million | -3.25 Million | -1.65 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.19 Million | -7.81 Million | -6.87 Million | -27.8 Million | -9.24 Million | -5.83 Million |
| Depreciation & Amortization | 626 Thousand | 637 Thousand | 652 Thousand | 2.62 Million | 751 Thousand | 630 Thousand |
| Deferred income taxes | - | - | 3.79 Million | 1.85 Million | 2.92 Million | -736 Thousand |
| Stock-based compensation | 28 Thousand | 47 Thousand | 194 Thousand | 870 Thousand | 109 Thousand | 14 Thousand |
| Change in working capital | 4.26 Million | 1.64 Million | 6.46 Million | 4.21 Million | 4.06 Million | 3.21 Million |
| Other non-cash items | 2.09 Million | 567 Thousand | -2.76 Million | 2.54 Million | -1.26 Million | 1.45 Million |
| Investing Cash Flow | - | 1.28 Million | 225 Thousand | -5.55 Million | -5.02 Million | -111 Thousand |
| Investments in PPE | - | -40 Thousand | -50 Thousand | -5.55 Million | -5.02 Million | -111 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 1.32 Million | 275 Thousand | -5.07 Million | -5 Million | - |
| Financing Cash Flow | -248 Thousand | -624 Thousand | 620 Thousand | 6.18 Million | 5.05 Million | 1.24 Million |
| Debt repayment | -62 Thousand | -564 Thousand | -680 Thousand | -224 Thousand | -60 Thousand | -57 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 3.92 Million | 3.92 Million | - |
| Other Financing Activities | -4000.00 | -40 Thousand | 1.3 Million | 2.49 Million | 1.19 Million | 1.3 Million |
| Accounts receivables | 836 Thousand | -476 Thousand | 1.43 Million | -1.13 Million | -1.2 Million | 1.2 Million |
| Accounts payables | - | 228 Thousand | 4.43 Million | 3.02 Million | 1.65 Million | 840 Thousand |
| Inventory | 1.48 Million | 2.95 Million | -567 Thousand | -1.77 Million | 1.51 Million | 382 Thousand |
| Other working capital | 934 Thousand | -1.06 Million | 1.17 Million | 4.09 Million | 2.09 Million | 789 Thousand |
| Cash at beginning of period | 6.89 Million | 9.58 Million | 7.5 Million | 22.5 Million | 9.77 Million | 10.11 Million |
| Cash at end of period | 7.12 Million | 6.89 Million | 9.58 Million | 7.5 Million | 7.5 Million | 9.77 Million |
| Capital Expenditure | - | -40 Thousand | -50 Thousand | -5.55 Million | -5.02 Million | -111 Thousand |
| Effect of forex changes on cash | 32 Thousand | 173 Thousand | -233 Thousand | 60 Thousand | 372 Thousand | -216 Thousand |
| Net cash flow / Change in cash | 235 Thousand | -2.69 Million | 2.08 Million | -14.99 Million | -2.27 Million | -343 Thousand |
| Free Cash Flow | 451 Thousand | -3.57 Million | 1.42 Million | -21.24 Million | -7.69 Million | -1.37 Million |
VNUE
PTMP
688670
VSBGF
NTLA
6698